Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
Inari is poised to enhance Stryker's footprint ... The company’s portfolio of mechanical thrombectomy devices is set to ‘complement’ Stryker’s neurovascular division.
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.
Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system.
Inari shareholders are getting a fair price ... stents, and mechanical thrombectomy devices. It’s a business that Stryker has built through a combination of internal R&D and M&A, including ...